Erythropoietin: Repair of the Failing Heart**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology-Reference-Cited by-同舟云学术

Erythropoietin: Repair of the Failing Heart**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology

Published:2006-07 Issue:1 Volume:48 Page:185-186
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

van der Meer Peter,Lipsic Erik

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Incidence and epidemiology of heart failure;Kannel;Heart Fail Rev,2000

2. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology;Swedberg;Eur Heart J,2005

3. Unchain my heart;Dimmeler;J Clin Invest,2005

4. Bone marrow cells regenerate infarcted myocardium;Orlic;Nature,2001

5. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts;Murry;Nature,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefits of Sodium–Glucose Cotransporter 2 Inhibitors and the Mechanisms Underlying Their Cardiovascular Effects;JACC: Asia;2022-06

2. The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice;International Journal of Molecular Sciences;2021-12-21

3. Proposed mechanisms of systemic cardiovascular action of gliflosins;Reviews on Clinical Pharmacology and Drug Therapy;2021-05-21

4. Application of Erythropoietin in Chronic Heart Failure Treatment;Mini-Reviews in Medicinal Chemistry;2021-01-14

5. Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial;Cardiovascular Diabetology;2020-09-25